BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 30353652)

  • 1. Cell type-selective pathways and clinical associations of lysophosphatidic acid biosynthesis and signaling in the ovarian cancer microenvironment.
    Reinartz S; Lieber S; Pesek J; Brandt DT; Asafova A; Finkernagel F; Watzer B; Nockher WA; Nist A; Stiewe T; Jansen JM; Wagner U; Konzer A; Graumann J; Grosse R; Worzfeld T; Müller-Brüsselbach S; Müller R
    Mol Oncol; 2019 Feb; 13(2):185-201. PubMed ID: 30353652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity and clinical relevance of autotaxin and lysophosphatidic acid pathways in high-grade serous carcinoma.
    Onallah H; Catane LJ; Tropé CG; Hetland Falkenthal TE; Reich R; Davidson B
    Virchows Arch; 2018 Oct; 473(4):463-470. PubMed ID: 30032361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study.
    Yu X; Zhang Y; Chen H
    BMC Cancer; 2016 Nov; 16(1):846. PubMed ID: 27809800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism.
    Seo EJ; Kwon YW; Jang IH; Kim DK; Lee SI; Choi EJ; Kim KH; Suh DS; Lee JH; Choi KU; Lee JW; Mok HJ; Kim KP; Matsumoto H; Aoki J; Kim JH
    Stem Cells; 2016 Mar; 34(3):551-64. PubMed ID: 26800320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells.
    Ren J; Xiao YJ; Singh LS; Zhao X; Zhao Z; Feng L; Rose TM; Prestwich GD; Xu Y
    Cancer Res; 2006 Mar; 66(6):3006-14. PubMed ID: 16540649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancer.
    Lee Z; Swaby RF; Liang Y; Yu S; Liu S; Lu KH; Bast RC; Mills GB; Fang X
    Cancer Res; 2006 Mar; 66(5):2740-8. PubMed ID: 16510595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol Contrasts LPA-Induced Ovarian Cancer Cell Migration and Platinum Resistance by Rescuing Hedgehog-Mediated Autophagy.
    Ferraresi A; Esposito A; Girone C; Vallino L; Salwa A; Ghezzi I; Thongchot S; Vidoni C; Dhanasekaran DN; Isidoro C
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831435
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis.
    Tigyi GJ; Yue J; Norman DD; Szabo E; Balogh A; Balazs L; Zhao G; Lee SC
    Adv Biol Regul; 2019 Jan; 71():183-193. PubMed ID: 30243984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LPA3 is a precise therapeutic target and potential biomarker for ovarian cancer.
    Zhao P; Yun Q; Li A; Li R; Yan Y; Wang Y; Sun H; Damirin A
    Med Oncol; 2022 Jan; 39(2):17. PubMed ID: 34982278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrity of SOS1/EPS8/ABI1 tri-complex determines ovarian cancer metastasis.
    Chen H; Wu X; Pan ZK; Huang S
    Cancer Res; 2010 Dec; 70(23):9979-90. PubMed ID: 21118970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lysophosphatidic acid-regulated signal transduction network in ovarian cancer cells and its role in actomyosin dynamics, cell migration and entosis.
    Ojasalu K; Lieber S; Sokol AM; Nist A; Stiewe T; Bullwinkel I; Finkernagel F; Reinartz S; Müller-Brüsselbach S; Grosse R; Graumann J; Müller R
    Theranostics; 2023; 13(6):1921-1948. PubMed ID: 37064875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells.
    Yu S; Murph MM; Lu Y; Liu S; Hall HS; Liu J; Stephens C; Fang X; Mills GB
    J Natl Cancer Inst; 2008 Nov; 100(22):1630-42. PubMed ID: 19001604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidic acid induction of urokinase plasminogen activator secretion requires activation of the p38MAPK pathway.
    Estrella VC; Eder AM; Liu S; Pustilnik TB; Tabassam FH; Claret FX; Gallick GE; Mills GB; Wiener JR
    Int J Oncol; 2007 Aug; 31(2):441-9. PubMed ID: 17611702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive and lysophosphatidic acid (LPA)-induced LPA production: role of phospholipase D and phospholipase A2.
    Eder AM; Sasagawa T; Mao M; Aoki J; Mills GB
    Clin Cancer Res; 2000 Jun; 6(6):2482-91. PubMed ID: 10873103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon signaling in ascites-associated macrophages is linked to a favorable clinical outcome in a subgroup of ovarian carcinoma patients.
    Adhikary T; Wortmann A; Finkernagel F; Lieber S; Nist A; Stiewe T; Wagner U; Müller-Brüsselbach S; Reinartz S; Müller R
    BMC Genomics; 2017 Mar; 18(1):243. PubMed ID: 28327095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysophosphatidic acid activates lipogenic pathways and de novo lipid synthesis in ovarian cancer cells.
    Mukherjee A; Wu J; Barbour S; Fang X
    J Biol Chem; 2012 Jul; 287(30):24990-5000. PubMed ID: 22665482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian cancer cell-derived lysophosphatidic acid induces glycolytic shift and cancer-associated fibroblast-phenotype in normal and peritumoral fibroblasts.
    Radhakrishnan R; Ha JH; Jayaraman M; Liu J; Moxley KM; Isidoro C; Sood AK; Song YS; Dhanasekaran DN
    Cancer Lett; 2019 Feb; 442():464-474. PubMed ID: 30503552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidic Acid Receptor Signaling in the Human Breast Cancer Tumor Microenvironment Elicits Receptor-Dependent Effects on Tumor Progression.
    Benesch MGK; Wu R; Tang X; Brindley DN; Ishikawa T; Takabe K
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37372960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LPA-induced migration of ovarian cancer cells requires activation of ERM proteins via LPA
    Park J; Jang JH; Oh S; Kim M; Shin C; Jeong M; Heo K; Park JB; Kim SR; Oh YS
    Cell Signal; 2018 Apr; 44():138-147. PubMed ID: 29329782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome.
    Reinartz S; Finkernagel F; Adhikary T; Rohnalter V; Schumann T; Schober Y; Nockher WA; Nist A; Stiewe T; Jansen JM; Wagner U; Müller-Brüsselbach S; Müller R
    Genome Biol; 2016 May; 17(1):108. PubMed ID: 27215396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.